KEVIN SPONSELLER: Open Payments
NPI 1851709554 · HARTSVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,629 in 168 payments from 32 companies in 2025. Trend: 2023 $2,982 · 2024 $3,022 · 2025 $2,629
Food & beverage: $2,629
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $475 |
| PFIZER INC. | 16 | $289 |
| Novo Nordisk Inc | 14 | $225 |
| AstraZeneca Pharmaceuticals LP | 12 | $213 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 11 | $170 |
| Lilly USA, LLC | 10 | $144 |
| Abbott Laboratories | 7 | $116 |
| Otsuka America Pharmaceutical, Inc. | 4 | $82 |
| Viatris Specialty LLC | 4 | $82 |
| Corcept Therapeutics | 4 | $81 |
Products named: VRAYLAR, JARDIANCE, NURTEC ODT, REXULTI, UBRELVY, MOUNJARO, FREESTYLE LIBRE 3, FARXIGA.
Industry payments across SC — which companies pay providers there.
